返回期刊详情

Breast

IF7.9

论文数8953

被引数8179

期刊论文 8953

发表时间

Impact of old age, comorbidity, and polypharmacy on adjuvant endocrine therapy for patients with early-stage breast cancer 老年、合并症和多药治疗对早期乳腺癌患者辅助内分泌治疗的影响

Breast

IF7.9

2026-10-27

OAAI

Chunhuan Lao; Marion Kuper-Hommel; Ian Campbell; Ineke Meredith; Abbey Wrigley; Ross Lawrenson

Knowledge gaps and future perspectives for the definition, diagnostics and treatment of isolated locoregional recurrent breast cancer.孤立性局部区域复发乳腺癌的定义、诊断和治疗中的知识空白及未来展望

Breast

IF7.9

2026-10-21

OAAI

Tess I.M. Snellen; Charlotte M. Vervenne; Vincent O. Dezentjé; Terry Wiersma; Astrid N. Scholten; Esther H. Lips; Marie-Jeanne T.F.D. Vrancken Peeters

Longitudinal Trajectories of Menopausal Symptoms in Women Receiving Endocrine Therapy for Breast Cancer Compared With Natural Menopause 接受内分泌治疗乳腺癌妇女更年期症状的纵向轨迹与自然绝经的比较

Breast

IF7.9

2026-10-21

OAAI

Se Kyung Lee; Hye Rin Choi; Danbee Kang; Yoonyoung Jang; Seungho Ryu; Jeong Eon Lee; Seok Jin Nam; Seok Won Kim; Byung Joo Chae; Jai Min Ryu; Yoosoo Chang; Jonghan Yu

Current state and future potential of radiopharmaceutical therapy in breast cancer 放射性药物疗法在乳腺癌中的现状与未来潜力

Breast

IF7.9

2026-10-17

OAAI

Joyce O’Shaughnessy; Neil K. Taunk; Gary A. Ulaner

Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort 与转移性乳腺癌一线抗HER2为基础治疗中表现出非凡疗效相关的临床特征：来自ESME国家队列的真实世界数据

Breast

IF7.9

2026-10-13

OAAI

Thomas Grinda; Matthieu Carton; Stefania Morganti; Audrey Mailliez; Christelle Levy; Thierry Petit; Thomas Bachelot; Monica Arnedos; Véronique Diéras; Vincent Massard; Florence Dalenc; Isabelle Desmoulins; Jean-Yves Pierga; Anthony Gonçalves; Caroline Bailleux; Jean-Sebastien Frenel; Lise Bosquet; Heather A. Parsons; William Jacot; Nancy U. Lin

Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and contralateral breast cancer recurrence 比利时对INFLUENCE 3.0模型的验证：预测5年局部区域和对侧乳腺癌复发

Breast

IF7.9

2026-10-07

OAAI

Aline Van der Vorst; Carlijn Grimberg; Marissa C. van Maaren; Tom A. Hueting; Caroline Weltens; Sabine Siesling; Catharina G.M. Groothuis-Oudshoorn

Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system 抗HER2疗法对巴西公共医疗保健系统中HER2阳性II期和III期乳腺癌潜在可避免死亡的影响

Breast

IF7.9

2026-10-01

OAAI

André Mattar; Francisco Pimentel Cavalcante; Nelson Francisco Correa-Netto; Iago Silveira; Eduardo Baldassin Pavanel; Cintia S. Kurokawa La Scala; Patricia Klarmann Ziegelmann

Effect of dose-dense adjuvant chemotherapy in patients with node-positive early breast cancer according to estrogen receptor levels: an exploratory analysis of the GIM2 trial 根据雌激素受体水平，剂量密集型辅助化疗对淋巴结阳性早期乳腺癌患者的影响：GIM2试验的探索性分析

Breast

IF7.9

2026-09-29

OAAI

Carmine De Angelis; Alessandra Rosa; Virginia Delucchi; Francesca Poggio; Mario Giuliano; Michelino De Laurentiis; Anita Rimanti; Anna Turletti; Angela Vaccaro; Alessandra Fabi; Simona Gasparro; Ornella Garrone; Fabio Puglisi; Barbara Cardinali; Piero Fregatti; Matteo Lambertini; Luca Boni; Eva Blondeaux; Lucia Del Mastro

Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database 人表皮生长因子受体2低表达、激素受体阳性转移性乳腺癌的化疗结局：来自法国多中心ESME数据库的见解

Breast

IF7.9

2026-09-27

OAAI

William Jacot; Pauline Macouillard; Suyuan Zhang; Danalyn Byng; Shannon Hunter; Vincent Massard; Jean-Sébastien Frenel; David Pérol; Etienne Brain; Audrey Mailliez; Thomas Bachelot; Monica Arnedos; Lise Bosquet; Véronique Diéras

Subtype-specific screen-detected and interval breast cancer rates in population screening: a BreastScreen Queensland cohort study 人口筛查中基于筛查检出和间隔期的乳腺癌亚型特异性检出率：一项乳腺癌筛查昆士兰州队列研究

Breast

IF7.9

2026-09-26

OAAI

Naomi Noguchi; Nick Ormiston-Smith; Michael Luke Marinovich; Julie Moore; Nehmat Houssami

Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons 与其它紫杉烷类相比nab-紫杉醇在早期乳腺癌中的疗效分析：一项揭示日历时间偏倚在真实世界药物比较中关键作用的研究

Breast

IF7.9

2026-09-25

OAAI

Jingjing Xiao; Meiling Huang; Changjiao Yan; Zhe Wang; Ting Wang

Prospective Assessment of Incomplete Ovarian Suppression in Breast Cancer using LC-MS/MS and Immunoassays for Estradiol 乳腺癌中不完全卵巢抑制的前瞻性评估：使用LC-MS/MS和免疫分析法检测雌二醇

Breast

IF7.9

2026-09-22

OAAI

Catherine M. Kelly; Lajos Pusztai; Kathleen Bennett; Siun Walsh; Mohammed Z. Zamer; Emily Harrold; Shahid Iqbhal; Janice M. Walshe; Michaela J. Higgins; Caitriona Cahir; Keith Mulready

Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study 残余胆固醇炎症指数预测乳腺癌新辅助治疗病理完全缓解：一项多中心外部验证研究

Breast

IF7.9

2026-09-22

OAAI

Galip Can Uyar; Kadriye Başkurt; Ahmet Oruç; Nargiz Majidova; Orhun Akdoğan; Enes Yeşilbaş; Kadriye Bir Yücel; Melek Karakurt Eryılmaz; Osman Sütcüoğlu; Ömür Berna Çakmak Öksüzoğlu; Mustafa Altınbaş

Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal 手术优先与术前新辅助化疗在I期（cT1c）三阴性乳腺癌中的比较：一项批判性再评价

Breast

IF7.9

2026-09-12

OAAI

M. Dediu; C. Zielinski; V. Preoteasa; A. Bulzan

Prognostic role of thymidine kinase 1 activity in hormone receptor positive metastatic breast cancer. A systematic review and meta-analysis 胸苷激酶1活性在激素受体阳性转移性乳腺癌中的预后作用：一项系统评价和荟萃分析

Breast

IF7.9

2026-09-09

OAAI

Ilenia Migliaccio; Roberto Buonaiuto; Giulia Anichini; Chiara Biagioni; Maria Letizia Cataldo; Svitlana Tyekucheva; Mattias Bergqvist; Christos Sotiriou; Laura Biganzoli; Carmine De Angelis; Luca Malorni

Which quality of life issues are important to patients with metastatic breast cancer: Phase 1 and 2 development of European Organisation for Research and Treatment of Cancer metastatic breast cancer module (EORTC QLQ-MBR)转移性乳腺癌患者关注的生活质量问题：欧洲癌症研究与治疗组织转移性乳腺癌模块（EORTC QLQ-MBR）的第一阶段和第二阶段开发

Breast

IF7.9

2026-09-05

OAAI

Christopher Bedding; Kate Absolom; Katarzyna Pogoda; Akihiko Shimomura; Hiroto Ishiki; Juan Ignacio Arraras; Julien Peron; Monica Pinto; Nora Nevries; Omar Shamieh; Tara Chalk; Teresa Young; Vesna Bjelic-Radisic; Waleed Alrjoub; Yuichiro Kikawa; Fatima Cardoso; Galina Velikova

Beyond breast-conservation rates: Measuring eligibility, offer, and choice after neoadjuvant chemotherapy 超越保乳手术率：新辅助化疗后评估患者资格、治疗建议和选择

Breast

IF7.9

2026-09-04

OAAI

Chukwumbana Faith Okirie

Clarification of oestrogen receptor thresholds and Allred scoring 雌激素受体阈值及Allred评分的阐明

Breast

IF7.9

2026-09-01

OAAI

Sang, Tony Yiu